Sirnaomics to Raise HK$206 Million via Share Subscription

MT Newswires Live09-08

Sirnaomics (HKG:2257) agreed to issue 17.35 million new shares at HK$12.00 each to four subscribers, raising about HK$206 million in net proceeds, according to a Monday Hong Kong bourse filing.

The subscription price represents a 19.8% discount to the Sept. 5 closing price of HK$14.97 but a nearly 1.6% premium to the five-day average.

The new shares equal 16.5% of the existing issued capital and will dilute to about 14.2% after completion.

Hong Kong unit of Shanghai-listed Bloomage Biotechnology (SHA:688363) will take 11.57 million shares and may nominate two directors to Sirnaomics' board.

The other investors include executive Tse Shek Ho and two private individuals through BVI entities.

Net proceeds will be used for general working capital.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment